GAMMA Investing »

Aardvark Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2k 388 5.76

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Micron Technology Common Stock (MU)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Eli Lilly Common Stock (LLY)
Tesla Common Stock (TSLA)
Ishares Tr National Mun Etf Etf (MUB)
Advanced Micro Devices Common Stock (AMD)

View all positions for GAMMA Investing

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Capital Management
Polygon Management
Geode Capital Management
Adage Capital Partners GP
State Street Corporation
Two Sigma Investments
UBS Group
AQR Capital Management
Millennium Management
Northern Trust
Vanguard Fiduciary Trust

View all funds holding Aardvark Therapeutics